CYTR Cash Flow Statement

Click line-items for a historical chart and %
Cash flows from operating activities:
Net loss -6.86M
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 29.54K
Retirement of fixed assets 0
Non-cash gain on transfer of RXi common stock
Stock option and warrant expense 308.01K
Fair value adjustment on warrant liability 2.1M
Changes in assets and liabilities:
Receivable 99.51K
Interest receivable -13.65K
Prepaid expenses and other current assets -250.06K
Income taxes recoverable
Accounts payable -1.21M
Accrued expenses and other current liabilities 88.77K
Net cash used in operating activities -5.91M
Cash flows from investing activities:
Net proceeds from sale of marketable securities
Proceeds from sale of assets held for sale
Proceeds from sale of unconsolidated subsidiary shares
Purchases of equipment and furnishings -2.44K
Net cash provided by investing activities 3M
Cash flows from financing activities:
Net proceeds from exercise of stock options
Net cash provided by financing activities
Net increase in cash and cash equivalents -2.91M
Cash and cash equivalents at beginning of period 14.34M
Cash and cash equivalents at end of period 11.43M
Supplemental disclosure of cash flow information:
Cash received during the period as interest income

Entities mentioned with CYTR

View All Entities